- 06-23-2008
Lupin Enters Into Marketing Alliance with ASCEND Therapeutics for SUPRAX® 400 mg Tablets in the U.S. - 10-01-2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal® to OB/GYNs - 09-27-2007
Columbia Laboratories Signs U.S. License and Supply Agreement with ASCEND Therapeutics to Market PROCHIEVE® 4% Progesterone Gel - 06-02-05
Study of ASCEND's 4-OHT Gel Published in Journal of Clinical Oncology - 05-11-05
ASCEND Therapeutics Announces Study Results from Phase 2 Cyclic Breast Pain Study - 08-11-04
ASCEND Therapeutics Files Patent Applications for Drug Planned to Treat Benign Breast Disease - 07-16-04
ASCEND Therapeutics Launches Andrin Trial in Australia - 07-07-04
ASCEND Therapeutics Acquires North American Product Rights for New Product - 06-07-04
Thin Skinned - VA Newswire article (.pdf) - 05-10-04
ASCEND Therapeutics Raises Awareness of Breast Pain and Density Concerns During National Women's Health Week - 02-10-04
Ascend Announces Scientific Advisory Board - 02-05-04
ASCEND Therapeutics, Inc. Acquires North American Product Rights: New Estrogen Inhibitor in Phase II Clinical Development - 12-06-03
Ascend Therapeutics, Inc. Presents Positive Data From Phase 2 Breast Tumor Cell Proliferation Cell Study At Annual San Antonio Breast Cancer Symposium - 11-24-03
ASCEND Therapeutics, Inc. Presents Phase 2 Data From Breast Tumor Cell Proliferation Study - 06-18-03
ASCEND Therapeutics, Inc. Files Patent Application for the Prevention and Treatment of Breast Cancer Utilizing a Gel Formulation of a Tamoxifen Derivative - 04-30-03
ASCEND Therapeutics, Inc. Initiates Clinical Trial For Cyclic Mastalgia - 02-26-03
ASCEND Therapeutics, Inc. Files Patent Applications - 11-19-02
ASCEND Therapeutics Launched
